Ingenium Therapeutics
- Biotech or pharma, therapeutic R&D
Ingenium Therapeutics is a clinical-stage biotech company focusing on developing allogenic PBMC-derived Memory NK cells. Our lead pipeline, Gengleucel, is in Phase 2 stage for the treatment of AML.
Other cutting edge immune oncology pipelines are in preclinical status (Car memory NK, in vivo CAR-NK etc.)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}